Comment on Chun et al, “A Randomized Phase II Study of Perioperative Chemotherapy Plus Bevacizumab Versus Postoperative Chemotherapy Plus Bevacizumab in Patients With Upfront Resectable Hepatic Colorectal Metastases”

Comment on Chun et al, “A Randomized Phase II Study of Perioperative Chemotherapy Plus Bevacizumab Versus Postoperative Chemotherapy Plus Bevacizumab in Patients With Upfront Resectable Hepatic Colorectal Metastases” / Gelsomino, F., Spallanzani, A., Casadei Gardini, A.. - In: CLINICAL COLORECTAL CANCER. - ISSN 1533-0028. - 19:4(2020), pp. e262-e263. [10.1016/j.clcc.2020.06.002]